In summary, miR-17-92 is a downstream effector of fibroblast growth factor receptor 1 (FGFR1) in BCR-FGFR1-driven B-cell lymphoblastic leukemia [63]. The gene discussed is FGFR1; the disease is precursor B-cell acute lymphoblastic leukemia.